Your browser doesn't support javascript.
loading
Outcomes based on histopathologic response to preoperative chemotherapy in children with bilateral Wilms tumor: A prospective study (COG AREN0534).
Chintagumpala, Murali M; Perlman, Elizabeth J; Tornwall, Brett; Chi, Yueh-Yun; Kim, Yeonil; Hoffer, Fredric A; Kalapurakal, John A; Warwick, Anne B; Shamberger, Robert C; Khanna, Geetika; Hamilton, Thomas E; Gow, Kenneth W; Paulino, Arnold C; Gratias, Eric J; Mullen, Elizabeth A; Geller, James I; Fernandez, Conrad V; Ritchey, Michael L; Grundy, Paul E; Dome, Jeffrey S; Ehrlich, Peter F.
Afiliación
  • Chintagumpala MM; Texas Children's Cancer Center, Baylor College of Medicine, Houston, Texas.
  • Perlman EJ; Department of Pathology, Ann and Robert H. Lurie Children's Hospital, Chicago, Illinois.
  • Tornwall B; Department of Biostatistics, College of Public Health & Health Professions and College of Medicine, University of Florida, Gainesville, Florida.
  • Chi YY; Cancer and Blood Disease Institute, Children's Hospital Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles, California.
  • Kim Y; Merck Research Laboratories, Merck & Company Inc, Rahway, New Jersey.
  • Hoffer FA; Department of Radiology, Fred Hutchison Cancer Center, University of Washington, Seattle, Washington.
  • Kalapurakal JA; Department of Radiation Oncology, Northwestern Memorial Hospital, Northwestern University, Chicago, Illinois.
  • Warwick AB; Department of Pediatrics, Uniformed Services University, Walter Reed National Military Medical Center, Washington, DC.
  • Shamberger RC; Department of Surgery, Boston Children's Hospital and Dana Farber Cancer Center, Boston, Massachusetts.
  • Khanna G; School of Medicine, Washington University of St Louis, St Louis, Missouri.
  • Hamilton TE; Department of Surgery, Boston Children's Hospital and Dana Farber Cancer Center, Boston, Massachusetts.
  • Gow KW; Department of Surgery, University of Washington, Seattle, Washington.
  • Paulino AC; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Gratias EJ; Children's Oncology Group, Philadelphia, Pennsylvania.
  • Mullen EA; Department of Surgery, Boston Children's Hospital and Dana Farber Cancer Center, Boston, Massachusetts.
  • Geller JI; Division of Hematology/Oncology, Cincinnati Children's Hospital, Cincinnati, Ohio.
  • Fernandez CV; Pediatrics and Bioethics, IWK Health Center, Halifax, Nova Scotia, Canada.
  • Ritchey ML; Department of Urology, Phoenix Children's Hospital, Phoenix, Arizona.
  • Grundy PE; Department of Pediatrics and Oncology, University of Alberta Children's Hospital, Edmonton, Alberta, Canada.
  • Dome JS; Pediatric Surgery, Children's National Hospital and George Washington University School of Medicine and Health Sciences, Washington, DC.
  • Ehrlich PF; Section of Pediatric Surgery, C.S. Mott Children's Hospital, University of Michigan, Ann Arbor, Michigan.
Cancer ; 128(13): 2493-2503, 2022 07 01.
Article en En | MEDLINE | ID: mdl-35383900

Texto completo: 1 Colección: 01-internacional Asunto principal: Tumor de Wilms / Neoplasias Renales Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Child / Humans / Infant Idioma: En Revista: Cancer Año: 2022 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Asunto principal: Tumor de Wilms / Neoplasias Renales Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Child / Humans / Infant Idioma: En Revista: Cancer Año: 2022 Tipo del documento: Article